Alibaba Health Information Technology (FRA:TWYA) EBITDA: €280 Mil (TTM As of Mar. 2026)


FRA:TWYA Alibaba Health Information Technology Ltd FRA:TWYA
83 GF Score
Price €5.90
GF Value €9.99
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology EBITDA?

Alibaba Health Information Technology FRA:TWYA -3.28% 83 EBITDA is €280 Mil as of Mar. 2026. GuruFocus rates FRA:TWYA with a GF Score™ of 83/100 and a GF Value™ of €9.99 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Alibaba Health Information Technology's EBITDA for the six months ended in Mar. 2026 was €106 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €280 Mil.

During the past 12 months, the average EBITDA Growth Rate of Alibaba Health Information Technology was 48.80% per year. During the past 3 years, the average EBITDA Growth Rate was 54.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Alibaba Health Information Technology was 106.30% per year. The lowest was -109.60% per year. And the median was -24.70% per year.

Alibaba Health Information Technology's EBITDA per Share for the six months ended in Mar. 2026 was €0.13. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.35.

During the past 12 months, the average EBITDA per Share Growth Rate of Alibaba Health Information Technology was 48.10% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 45.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Alibaba Health Information Technology was 95.10% per year. The lowest was -78.30% per year. And the median was -8.40% per year.

Alibaba Health Information Technology  (FRA:TWYA) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Alibaba Health Information Technology EBITDA Related Terms


Alibaba Health Information Technology EBITDA Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology EBITDA Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.92 84.11 127.63 206.73 285.60

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.61 108.10 98.41 173.85 106.14

Alibaba Health Information Technology EBITDA Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's EV-to-EBITDA falls into.


FRA:TWYA
83GF Score
Alibaba Health Information Technology Ltd FRA:TWYA
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Alibaba Health Information Technology's EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Alibaba Health Information Technology's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2026, Alibaba Health Information Technology's EBITDA was €286 Mil.

Alibaba Health Information Technology's EBITDA for the quarter that ended in Mar. 2026 is calculated as

Alibaba Health Information Technology's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2026, Alibaba Health Information Technology's EBITDA was €106 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €280 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of €280 Mil mean?
Alibaba Health Information Technology (FRA:TWYA) has a EBITDA of €280 Mil as of Mar. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Alibaba Health Information Technology.
Is Alibaba Health Information Technology's EBITDA too high?
Alibaba Health Information Technology's current EBITDA is €280 Mil. Overall, Alibaba Health Information Technology has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's EBITDA compare to competitors?
Alibaba Health Information Technology's EBITDA of €280 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Healthcare Providers & Services company?
A good EBITDA depends on the Healthcare Providers & Services industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Alibaba Health Information Technology. Alibaba Health Information Technology's current EBITDA is €280 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (FRA:TWYA) is currently considered Significantly Undervalued. The stock's GF Value™ is €9.99, compared to a current price of €5.90 — trading 40.9% below its estimated fair value. The current EBITDA is €280 Mil. Alibaba Health Information Technology's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Alibaba Health Information Technology (FRA:TWYA), the current EBITDA is €280 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (FRA:TWYA) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of €5.90 is trading 40.9% below its estimated GF Value™ of €9.99. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for FRA:TWYA:

  • EBITDA: €280 Mil
  • GF Value™: €9.99 vs. price of €5.90 (40.9% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the FRA:TWYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
83GF Score

Get the complete analysis for FRA:TWYA

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.90
Price
€9.99
GF Value